A new generation of research looks at psilocybin, LSD and other mind-altering drugs. Both the challenges and the therapeutic promise are enormous.
New genetic sequencing technologies have opened the door to animal venom therapies.
Adversity in early childhood too often equals poor health later. Now researchers are looking for ways to change the equation.
The war in Ukraine has revived worries about nuclear violence. New or improved treatments for radiation poisoning are in the works.
New digital and hybrid approaches to clinical trials are quickly gaining ground. Are they moving too fast?
Patients with terminal cancer now have more treatment options. Will that help or hurt?
Once regarded as a purely mental condition, functional neurological disorder emerges from the shadows.
Large trials deliver results based on averages, not individuals. The N-of-1 model is a plucky—but labor-intensive—way to right the system.
Medical journals have a blind spot when it comes to race. But a blueprint for change is beginning to emerge.
No Articles Found.